메뉴 건너뛰기
The Lancet
Volumn 380, Issue 9840, 2012, Pages 470-471
Authors' reply
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC ACTIVITY; ARTIFICIAL EMBOLISM; ASIA; CANCER SCREENING; CHEMOEMBOLIZATION; HUMAN; INFERIOR CAVA VEIN OBSTRUCTION; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR;
EID: 84864740484     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/s0140-6736(12)61286-0     Document Type: Letter
Times cited : (11)
References (5)
  • 1
    • 80052949031 scopus 로고    scopus 로고
    • Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?
    • Poustchi H, Farrell GC, Strasser SI, Lee AU, McCaughan GW, George J. Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology 2011; 54: 1998-2004.
    • (2011) Hepatology , vol.54 , pp. 1998-2004
    • Poustchi, H.1    Farrell, G.C.2    Strasser, S.I.3    Lee, A.U.4    McCaughan, G.W.5    George, J.6
  • 2
    • 79952231921 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma: An update
    • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-22.
    • (2011) Hepatology , vol.53 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 3
    • 84858658381 scopus 로고    scopus 로고
    • Easl-eortc. Management of hepatocellular carcinoma
    • EASL-EORTC. Management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-43.
    • (2012) J Hepatol , vol.56 , pp. 908-943
  • 4
    • 79953292241 scopus 로고    scopus 로고
    • Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
    • Oliveri RS, Wetterslev J, Gluud C. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev 2011; 3: CD004787.
    • (2011) Cochrane Database Syst Rev , vol.3
    • Oliveri, R.S.1    Wetterslev, J.2    Gluud, C.3
  • 5
    • 84858701791 scopus 로고    scopus 로고
    • Chemoembolization for intermediate hcc: Is there proof of survival benefit?
    • Forner A, Llovet JM, Bruix J. Chemoembolization for intermediate HCC: is there proof of survival benefit? J Hepatol 2012; 56: 984-86.
    • (2012) J Hepatol , vol.56 , pp. 984-986
    • Forner, A.1    Llovet, J.M.2    Bruix, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.